Savaria (TSE:SIS – Get Free Report) had its target price hoisted by stock analysts at Scotiabank from C$29.00 to C$30.00 in a research note issued on Friday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Scotiabank’s price target would indicate a potential upside of 15.61% from the stock’s current price.
A number of other research analysts have also recently commented on SIS. Stifel Nicolaus raised their price target on shares of Savaria from C$28.00 to C$29.00 and gave the stock a “buy” rating in a research note on Friday. Raymond James Financial raised their target price on Savaria from C$27.00 to C$32.00 and gave the stock an “outperform” rating in a research report on Friday. Desjardins increased their price objective on Savaria from C$27.00 to C$32.00 and gave the stock a “buy” rating in a research note on Friday. National Bank Financial boosted their target price on shares of Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a research note on Friday. Finally, TD Securities upped their target price on shares of Savaria from C$27.00 to C$31.00 and gave the stock a “buy” rating in a report on Thursday. Seven investment analysts have rated the stock with a Buy rating, According to MarketBeat, Savaria has a consensus rating of “Buy” and a consensus target price of C$30.93.
View Our Latest Research Report on Savaria
Savaria Stock Performance
Savaria (TSE:SIS – Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. The company had revenue of C$241.78 million during the quarter. Savaria had a net margin of 6.90% and a return on equity of 10.24%. As a group, analysts predict that Savaria will post 1.2048518 earnings per share for the current fiscal year.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
